Contineum Therapeutics Inc

CTNMNASDAQ · USD
13.53USD0.00 (+2.43%)
259

Contineum Therapeutics Inc (CTNM) Straddle

CTNM straddle scan found 31 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 50.0%.

Read more

Trading a CTNM straddle lets you take a pure volatility position on Contineum Therapeutics Inc without committing to a direction. Contineum Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate CTNM straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on CTNM profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Contineum Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the CTNM straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. Its lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and progressive multiple sclerosis (MS). The company also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor to treat depression and relapse remitting MS; and CTX-343, a peripherally-restricted LPA1R antagonist.

Contineum Therapeutics, Inc. was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. The company was incorporated in 2009 and is headquartered in San Diego, California.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the CTNM straddle is the cleanest expression of that view. Our scanner prices every CTNM straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a CTNM straddle into a catalyst or short a CTNM straddle to harvest decay, the options straddle setups that matter are all in one place.

Apr 16, 202725.00$17.6521019%50.0%$42.65$7.350
Apr 16, 202722.50$15.9521019%46.7%$38.45$6.550
Jan 15, 202725.00$16.4511919%43.4%$41.45$8.550
Apr 16, 202720.00$14.6021019%40.8%$34.60$5.400
Dec 18, 202625.00$15.959119%40.7%$40.95$9.050
Jan 15, 202722.50$14.8511919%39.0%$37.35$7.650
Dec 18, 202622.50$14.209119%36.8%$36.70$8.301
Nov 20, 202620.00$10.906319%36.1%$30.90$9.100
Nov 20, 202622.50$13.286319%35.2%$35.78$9.230
Nov 20, 202617.50$9.036319%34.5%$26.53$8.480

As of September 18, 2026

Find the right straddle before volatility moves

Track CTNM straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.

Start your 14-day free trial